Express Pharma

Glenmark obtains ANDA approval for levonorgestrel and ethinyl estradiol tabs

Glenmark Pharmaceuticals Inc., US (Glenmark) has been granted final approval by the US Food and Drug Administration for the extended-cycle oral contraceptive, levonorgestrel/ethinyl estradiol tablets USP, 0.15 mg/0.03 mg, the AB-rated generic version of Seasonaleby Teva Women’s Health.

Comments are closed.